Showing results (781-790 of 7,535) with videos related to

Sort By:
Pageof 754
Molecular Pharmaceutics|December 23, 2008
Effects of polymer additives on the crystallization of hydrates: a molecular-level modulationFang Tian, Stefania Baldursdottir, Jukka Rantanen
Molecular Pharmaceutics|October 3, 2008
Caspase-3 gene silencing for inhibiting apoptosis in insulinoma cells and human isletsGuofeng Cheng, Lin Zhu, Ram I Mahato
Molecular Pharmaceutics|October 4, 2005
Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluationsDinesh Shenoy, Steven Little, Robert Langer, et al.
Molecular Pharmaceutics|October 4, 2005
Glucuronidation and the transport of the glucuronide metabolites in LLC-PK1 cellsJae H Chang, Leslie Z Benet
Molecular Pharmaceutics|July 20, 2005
The effect of food on the relative bioavailability of rapidly dissolving immediate-release solid oral products containing highly soluble drugsLawrence X Yu, Arthur B Straughn, Patrick J Faustino, et al.
Molecular Pharmaceutics|October 12, 2007
Single lipoplex study of cationic lipoid-DNA, self-assembled complexesEdwin V Pozharski, Robert C MacDonald
Molecular Pharmaceutics|October 24, 2007
Impact of surface derivatization of poly-L-lysine dendrimers with anionic arylsulfonate or succinate groups on intravenous pharmacokinetics and dispositionLisa M Kaminskas, Ben J Boyd, Peter Karellas, et al.
Molecular Pharmaceutics|August 21, 2007
Targeted therapy of breast and gynecological cancers with cytotoxic analogues of peptide hormonesJörg B Engel, Andrew V Schally, Johannes Dietl, et al.
Molecular Pharmaceutics|November 6, 2007
Intestinal and hepatic glucuronidation of flavonoidsLi Zhang, Zhong Zuo, Ge Lin
Molecular Pharmaceutics|March 22, 2007
Mechanistic studies of a peptidic GRP78 ligand for cancer cell-specific drug deliveryYing Liu, Sebastian C J Steiniger, YoungSoo Kim, et al.
Pageof 754